FierceBiotech ١٥ أبريل ٢٠٢٦ Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
FierceBiotech ٢٧ مارس ٢٠٢٦ Novartis pens $2B deal for allergy biotech with potential Xolair successor
FierceBiotech ٢٣ مارس ٢٠٢٦ Novartis joins Lilly, AZ in China expansion with $480M commitment to boost manufacturing, R&D
FierceBiotech ٢٠ مارس ٢٠٢٦ Novartis pays Synnovation $2B upfront for breast cancer program as rivals circle
FierceBiotech ٢٧ فبراير ٢٠٢٦ Atrium arises from Novartis' Avidity buy with $270M, pair of preclinical cardio candidates
FierceBiotech ١٨ فبراير ٢٠٢٦ Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal
FierceBiotech ٤ فبراير ٢٠٢٦ Novartis shakes up early pipeline with 6 culls and 2 new cancer candidates
FierceBiotech ١٨ ديسمبر ٢٠٢٥ Voyager jettisons 30 employees, Novartis hands back rights to 2 programs
FierceBiotech ٩ ديسمبر ٢٠٢٥ Novartis pens $1.7B immuno-dermatology pact with AI-enabled British biotech